Global Neurology Academy

Mastering ARIA Management: Charting the Path in a Virtual Clinic
Mastering ARIA Management: Charting the Path in a Virtual Clinic
CME/CE
Mastering ARIA Management: Charting the Path in a Virtual Clinic
0.25 credits
- James R. Bateman, MD, MPH
0.25 credits
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne Schindler, MD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options

Medical News

Medical News
Targeting Brain Enzymes to Combat Obesity: A New Frontier in Weight Control
news-medical.net
12/20/2024
Read more
Medical News
Breathing Rhythms Linked to Memory Consolidation During Sleep, Study Finds
news.northwestern.edu
12/20/2024
Read more
Medical News
Advancing Robotic Surgery: University Hospitals Implements Da Vinci 5
newswise.com
12/19/2024
Read more
Medical News
How Does AI Compare to Ophthalmologists in Diagnosing Infectious Keratitis?
medicalxpress.com
12/19/2024
Read more

See more news

CME/CE

Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credit
- Craig M. McDonald, MD
- Crystal Proud, MD
- Aravindhan Veerapandiyan, MD
1.00 credit
The Multiple Faces of ATTRv-PN
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
1.00 program credit
- Sami Khella, MD
- Marcia Waddington-Cruz, MD, PhD
1.00 program credit

Clinical Practice

AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Clinician's Roundtable
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD

Programs

An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
CME/CE
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
0.50 credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
0.50 credits
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
NeuroFrontiers
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
- Ashley Baker, MSN, PMHNP
- Desiree Matthews, PMHNP-BC
- Rakesh Jain, MD, MPH